CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 29 enrolled
Drug / intervention
CRAFT-FTbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04284813
NCT04284813N/ACompleted

Treatment Engagement in Families With Substance Use and Psychosis: A Pilot Study

Mclean Hospital·interventional·Posted Feb 26, 2020·Updated Oct 12, 2022

In Brief

A clinical study evaluating CRAFT-FT for Psychosis and 14 related conditions. Completed, enrolled 29 participants across 1 site.

Detailed Summary

The purpose of this study is to develop and evaluate an intervention that adapts Community Reinforcement and Family Training (CRAFT) for families experiencing first episode psychosis and substance use delivered via telemedicine (video conferencing). The intervention aims to improve treatment engagement and reduce distress, and it will be delivered via telemedicine (CRAFT-FT). To assess feasibility of the intervention, family members will complete the sessions and provide feedback to refine the treatment manual. Data on client relatives with psychosis will be collected for preliminary assessment purposes. Client relatives will not complete the research study intervention.

Study Details

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedFeb 26, 2020
Enrollment StartSep 24, 2020
Primary CompletionAug 25, 2021
Study CompletionJul 7, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 6.4 years ago

Interventions

CRAFT-FTbehavioral

CRAFT-FT will be delivered via telemedicine. Topics include building motivation, self-care, communication, understanding patterns of behavior, positive reinforcement, and negative consequences. The intervention will be tailored to families of individuals experiencing psychosis and substance use who are enrolled in first episode psychosis outpatient services. Participants will be asked to completed assessments at pre-treatment, mid-treatment (approximately week 3), post-treatment, and a follow-up assessment approximately 3 month post-treatment.